Fasting therapy for treating and preventing disease - Current state of evidence

Forschende Komplementarmedizin

Volumn 20, Issue 6, 2013, Pages 444-453

  Michalsen, Andreas ^a,b   Li, Chenying ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Immanuel Hospital   (Germany)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chronic diseases; Complementary treatment; Fasting; Salutogenesis

Indexed keywords

CALORIC RESTRICTION; CHRONIC DISEASE; DIET RESTRICTION; ENERGY METABOLISM; EVIDENCE BASED MEDICINE; HEALTH BEHAVIOR; HOMEOSTASIS; HUMAN; LIFESTYLE; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

CALORIC RESTRICTION; CHRONIC DISEASE; ENERGY METABOLISM; EVIDENCE-BASED MEDICINE; FASTING; HEALTH BEHAVIOR; HOMEOSTASIS; HUMANS; LIFE STYLE; NEUROSECRETORY SYSTEMS;

EID: 84893095767     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000357765     Document Type: Review

References (125)

1. Mattson MP, Wan R: Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 2005;16:129-137.
2. Buchinger O: Das Heilfasten und seine Hilfsmethoden. Stuttgart, Hippokrates, 1932.
3. Fahrner H: Die Fastenkur. Arztezeitschrift fur Naturheilverfahren 1991;7:544-548.
4. Lutzner H: Fasten. Bindlach, Gondrom, 2002.
5. Hartel U, Volger E: Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland - Ergebnisse einer reprasentativen Bevolkerungsstudie. Forsch Komplementarmed Klass Naturheilkd 2004;11:327-334.
6. Buchinger A: Fasting; in Nowey D (ed): Clinician's Complete Reference to Complementary and Alternative Medicine. Chicago, Mosby, 2002.
7. Lutzner H: Fasten/Fastentherapie: Grundlagen und Methodik; in Buhring M, Kemper FH, Matthiessen PF (eds): Naturheilverfahren und Unkonventionelle Medizinische Richtungen. Berlin, Springer LoseblattSysteme, 1998, pp 1-26.
8. Buchinger O: 40 years of fasting therapy. Hippokrates 1959;30:246-248.
9. Krauss H, Hartmann K: Studies on protein metabolism in therapeutic fasts. Arch Phys Ther (Leipz) 1964;16:109-122.
10. Owen OE, Smalley KJ, D'Alessio DA, Mozzoli MA, Dawson EK: Protein, fat, and carbohydrate requirements during starvation: Anaplerosis and cataplerosis. Am J Clin Nutr 1998;68:12-34.
11. Varady KA, Hellerstein MK: Alternate-day fasting and chronic disease prevention: A review of human and animal trials. Am J Clin Nutr 2007;86:7-13.
12. Varady KA, Bhutani S, Church EC, Klempel MC: Short-term modified alternate-day fasting: A novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 2009;90:1138-1143.
13. Michalsen A: Prolonged fasting as a method of mood enhancement in chronic pain syndromes: A review of clinical evidence and mechanisms. Curr Pain Headache Rep 2010;14:80-87.
14. Wilhelmi de Toledo F, Buchinger A, Burggrabe H, et al.: Leitlinien zur Fastentherapie. Forsch Komplementarmed Klass Naturheilkd 2002;9:189-199.
15. Fahrner H: Fasten als Therapie. Stuttgart, Hippokrates, 1991.
16. Shelton H: The Hygienic System: Fasting and Sun Bathing. San Antonio, Dr. Shelton's Health School, 1963.
17. Ramsey JJ, Colman RJ, Binkley NC, Christensen JD, Gresl TA, Kemnitz JW, Weindruch R: Dietary restriction and aging in rhesus monkeys: The University of Wisconsin study. Exp Gerontol 2000;35:1131-1149.
18. Fontana L, Partridge L, Longo VD: Extending healthy life span - from yeast to humans. Science 2010;328:321-326.
19. Holloszy JO: Mortality rate and longevity of foodrestricted exercising male rats: A reevaluation. J Appl Physiol 1997;82:399-403.
20. Liebscher D: Auswirkungen religiosen Fastens auf anthropometrische Parameter, Blutfettwerte und Hamodynamik normalgewichtiger gesunder Probanden. Dissertation, Medizinische Fakultat Carl Gustav Carus, Technische Universitat Dresden, 2012. www. qucosa.de/fileadmin/data/qucosa/documents/9629/Auswirkungen- religi%C3%B6sen-Fastens-auf-anthropometrische- Parameter,-Bluttfettwerte- und-H%C3%A4modynamik-normalgewichtiger- gesunder-Probanden.pdf (accessed on 05.12.2013).
21. Varady KA, Roohk DJ, Loe YC, McEvoy-Hein BK, Hellerstein MK: Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. J Lipid Res 2007;48:2212-2219.
22. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-187.
23. Merry BJ: Oxidative stress and mitochondrial function with aging - the effects of calorie restriction. Aging Cell 2004;3:7-12.
24. Kouda K, Iki M: Beneficial effects of mild stress (hormetic effects): Dietary restriction and health. J Physiol Anthropol 2010;29:127-132.
25. Mattson MP: Dietary factors, hormesis and health. Ageing Research Reviews 2008;7:43-48.
26. Poljsak B: Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011;2011:194586.
27. Varela A, Marina Prendes MG, Testoni G, Vazquez N, Astudilla C, Cerruti S, Savino EA: Influence of fasting on the effects of ischemic preconditioning in the ischemic-reperfused rat heart. Arch Physiol Biochem 2002;110:189-196.
28. Gredilla R, Sanz A, Lopez-Torres M, Barja G: Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. FASEB J 2001;15:1589-1591.
29. Ristow M, Schmeisser S: Extending life span by increasing oxidative stress. Free Radic Biol Med 2011;51:327-336.
30. Varady KA, Ebine N, Vanstone CA, Parsons WE, Jones PJ: Plant sterols and endurance training combine to favorably alter plasma lipid profiles in previously sedentary hypercholesterolemic adults after wk. Am J Clin Nutr 2004;80:1159-1166.
31. Hall JA, Dominy JE, Lee Y, Puigserver P: The sirtuin family's role in aging and age-associated pathologies. J Clin Invest 2013;123:973-979.
32. Choi AM, Ryter SW, Levine B: Autophagy in human health and disease. N Engl J Med 2013;368:651- 662.
33. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N: The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-1036.
34. Jia K, Levine B: Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007;3:597-599.
35. Sell DR: Ageing promotes the increase of early glycation Amadori product as assessed by epsilon- N-(2-furoylmethyl)-L-lysine (furosine) levels in rodent skin collagen. The relationship to dietary restriction and glycoxidation. Mech Ageing Dev 1997; 95:81-99.
36. Bierhaus A, Humpert PM, Stern DM, Arnold B, Nawroth PP: Advanced glycation end product receptor- mediated cellular dysfunction. Ann N Y Acad Sci 2005;1043:676-680.
37. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H: Restriction of advanced glycation end products improves insulin resistance in human type diabetes: Potential role of AGER1 and SIRT1. Diabetes Care 2011;34: 1610-1616.
38. Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H: Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 2008;173:327-336.
39. Iwashige K, Kouda K, Kouda M, Horiuchi K, Takahashi M, Nagano A, Tanaka T, Takeuchi H: Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis. J Physiol Anthropol Appl Human Sci 2004;23:19-24.
40. Brecchia G, Bonanno A, Galeati G, Federici C, Maranesi M, Gobbetti A, Zerani M, Boiti C: Hormonal and metabolic adaptation to fasting: Effects on the hypothalamic-pituitary-ovarian axis and reproductive performance of rabbit does. Domest Anim Endocrinol 2006;31:105-122.
41. Kim HG, Lim EY, Jung WR, Shin MK, Ann ES, Kim KL: Effects of treadmill exercise on hypoactivity of the hypothalamo-pituitary-adrenal axis induced by chronic administration of corticosterone in rats. Neurosci Lett 2008;434:46-49.
42. Park S, Sohn S, Kineman RD: Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: Lessons from the spontaneous dwarf rat. J Endocrinol 2004;180:369-378.
43. Fekete C, Singru PS, Sanchez E, Sarkar S, Christoffolete MA, Riberio RS, Rand WM, Emerson CH, Bianco AC, Lechan RM: Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. Endocrinology 2006;147:520-529.
44. Shahab M, Zaman W, Bashir K, Arslan M: Fastinginduced suppression of hypothalamic-pituitary-gonadal axis in the adult rhesus monkey: Evidence for involvement of excitatory amino acid neurotransmitters. Life Sci 1997;61:1293-1300.
45. Steiner J, LaPaglia N, Kirsteins L, Emanuele M, Emanuele N: The response of the hypothalamicpituitary- gonadal axis to fasting is modulated by leptin. Endocr Res 2003;29:107-117.
46. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
47. Silva JP, von Meyenn F, Howell J, Thorens B, Wolfrum C, Stoffel M: Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 2009;462:646-650.
48. Goehler L, Hahnemann T, Michael N, Oehme P, Steglich HD, Conradi E, Grune T, Siems WG: Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Prev Med 2000;30:95-102.
49. Palmblad J, Levi L, Burger A, Melander A, Westgren U, von Schenck H, Skude G: Effects of total energy withdrawal (fasting) on thelevels of growth hormone, thyrotropin, cortisol, adrenaline, noradrenaline, T4, T3, and rT3 in healthy males. Acta Med Scand 1977;201:15-22.
50. Bergendahl M, Vance ML, Iranmanesh A, Thorner MO, Veldhuis JD: Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men. J Clin Endocrinol Metab 1996;81:692-699.
51. Spark RF, Arky RA, Boulter PR, Saudek CD, O'Brian JT: Renin, aldosterone and glucagon in the natriuresis of fasting. N Engl J Med 1975;292:1335-1340.
52. Maoz E, Shamiss A, Peleg E, Salzberg M, Rosenthal T: The role of atrial natriuretic peptide in natriuresis of fasting. J Hypertens 1992;10:1041-1044.
53. Michalsen A, Kuhlmann MK, Ludtke R, Backer M, Langhorst J, Dobos GJ: Prolonged fasting in patients with chronic pain syndromes leads to late mood-enhancement not related to weight loss and fasting-induced leptin depletion. Nutr Neurosci 2006;9:195-200.
54. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S: Effects of short-term fasting on lipid kinetics in lean and obese woman. Am J Physiol 1999;276:E278-284.
55. Bergendahl M, Evans WS, Pastor C, Patel A, Iranmanesh A, Veldhuis JD: Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phase women - a clinical research center study. J Clin Endocrinol Metab 1999;84:883-894.
56. Ahima RS, Lazar MA: Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008;22:1023-1031.
57. Schweiger U, Broocks A, Tuschl RJ, Pirke KM: Serotonin turnover in rat brain during semistarvation with high-protein and high-carbohydrate diets. J Neural Transm 1989;77:131-139.
58. Curzon G, Joseph MH, Knott PJ: Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem 1972;19:1967-1974.
59. Ishida A, Nakajima W, Takada G: Short-term fasting alters neonatal rat striatal dopamine levels and serotonin metabolism: An in vivo microdialysis study. Brain Res Dev Brain Res 1997;104:131-136.
60. Knott PJ, Joseph MH, Curzon G: Effects of food deprivation and immobilization on tryptophan and other amino acids in rat brain. J Neurochem 1973; 20:249-251.
61. Huether G, Zhou D, Schmidt S, Wiltfang J, Ruther E: Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex. Biol Psychiatry 1997;41:1174-1180.
62. Lipecki R: Klinische Studie zur Effizienz einer kombinierten Heilfastenbehandlung als Migranetherapie. Dissertation, Universitat Wurzburg, 1990, pp 1-53.
63. Araya AV, Orellana X, Espinoza J: Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: Preliminary evidences. Endocrine 2008;33:300-304.
64. Fontan-Lozano A, Lopez-Lluch G, Delgado-Garcia JM, Navas P, Carrion AM: Molecular bases of caloric restriction regulation of neuronal synaptic plasticity. Mol Neurobiol 2008;38:167-177.
65. Stanek K, Gunstad J, Leahey T, Glickman E, Alexander T, Spitznagel MB, Juvancic Heltzel J, Murray L: Serum brain-derived neurotrophic factor is associated with reduced appetite in healthy older adults. J Nutr Health Aging 2008;12:183-185.
66. Mattson MP: The impact of dictary energy intake on cognitive aging. Front Aging Neurosci 2010;8:5.
67. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP: Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 2003;100:2911-2916.
68. Goggi J, Pullar IA, Carney SL, Bradford HF: Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 2002;941:34-42.
69. Rumajogee P, Madeira A, Verge D, Hamon M, Miquel MC: Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. J Neurochem 2002;83:1525-1528.
70. Komaki G, Tamai H, Sumioki H, Mori T, Kobayashi N, Mori K, Mori S, Nakagawa T: Plasma beta-endorphin during fasting in man. Horm Res 1990;33:239- 243.
71. Molina PE, Hashiguchi Y, Meijerink WJ, Naukam RJ, Boxer R, Abumrad NN: Modulation of endogenous opiate production: Effect of fasting. Biochem Biophys Res Commun 1995;207:312-317.
72. Hanus L, Avraham Y, Ben-Shushan D, Zolotarev O, Berry EM, Mechoulam R: Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Res 2003;983: 144-151.
73. Brown AJ: Low-carb diets, fasting and euphoria: Is there a link between ketosis and gamma-hydroxybutyrate (GHB) Med Hypotheses 2007;68:268- 271.
74. Maalouf M, Rho JM, Mattson MP: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009; 59:293-315.
75. White AM, Johnston CS, Swan PD, Tjonn SL, Sears B: Blood ketones are directly related to fatigue and perceived effort during exercise in overweight adults adhering to low-carbohydrate diets for weight loss: A pilot study. J Am Diet Assoc 2007;107:1792-1796.
76. Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA: The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 2007;48:793-800.
77. Hasebe N, Abe K, Sugiyama E, Hosoi R, Inoue O: Anticonvulsant effects of methyl ethyl ketone and diethyl ketone in several types of mouse seizure models. Eur J Pharmacol 2010;642:66-71.
78. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC 3rd, Burnham WM: Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 2003;54:219-226.
79. Zarnowska I, Luszczki JJ, Zarnowski T, Buszewicz G, Madro R, Czuczwar SJ, Gasior M: Pharmacodynamic and pharmacokinetic interactions between common antiepileptic drugs and acetone, the chief anticonvulsant ketone body elevated in the ketogenic diet in mice. Epilepsia 2009;50:1132-1140.
80. Stafstrom CE, Rho JM: The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012;3:59.
81. Darlington LG, Ramsey NW, Mansfield JR: Placebo- controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1986;1:236- 238.
82. Skoldstam L, Larsson L, Lindstrom FD: Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol 1979;8:249-255.
83. Uden AM, Trang L, Venizelos N, Palmblad J: Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Ann Rheum Dis 1983;42:45-51.
84. Hafstrom I, Ringertz B, Gyllenhammar H, Palmblad J, Harms-Ringdahl M: Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:585-592.
85. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Forre O: Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899- 902.
86. Muller H, Wilhelmi de Toledo F, Resch KL: Fasting followed by vegetarian diet in patients with rheumatoid arthritis: A systematic review. Scand J Rheumatol 2001;30:1-10.
87. Schmidt S, Stange R, Lischka E, Kiehntopf M, Deufel T, Loth D, Uhlemann C: Uncontrolled clinical study of the efficacy of ambulant fasting in patients with osteoarthritis. Forsch Komplementmed 2010;17:87-94.
88. Hargraves WA, Hentall ID: Analgesic effects of dietary caloric restriction in adult mice. Pain 2005; 114:455-461.
89. de los Santos-Arteaga M, Sierra-Dominguez SA, Fontanella GH, Delgado-Garcia JM, Carrion AM: Analgesia induced by dietary restriction is mediated by the kappa-opioid system. J Neurosci 2003;23: 11120-11126.
90. Michalsen A, Schneider S, Rodenbeck A, Ludtke R, Huether G, Dobos GJ: The short-term effects of fasting on the neuroendocrine system in patients with chronic pain syndromes. Nutr Neurosci 2003;6:11-18.
91. Michalsen A, Riegert M, Ludtke R, Backer M, Langhorst J, Schwickert M, Dobos GJ: Mediterranean diet or extended fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: An observational study. BMC Complement Altern Med 2005;5:22.
92. Michalsen A, Li C, Kaiser K, Ludtke R, Meier L, Stange R, Kessler C: In-patient treatment of fibromyalgia: A controlled nonrandomized comparison of conventional medicine versus integrative medicine including fasting therapy. Evid Based Complement Alternat Med 2013;2013:908610.
93. Michalsen A, Hoffmann B, Moebus S, Backer M, Langhorst J, Dobos GJ: Incorporation of fasting therapy in an integrative medicine ward: Evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med 2005;11:601-607.
94. Goldhamer AC, Lisle DJ, Sultana P, Anderson SV, Parpia B, Hughes B, Campbell TC: Medically supervised water-only fasting in the treatment of borderline hypertension. J Altern Complement Med 2002; 8:643-650.
95. Schwartz MW, Seeley RJ: Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. N Engl J Med 1997;336:1802-1811.
96. Muller H, Wilhelmi de Toledo F, Schuck P, Resch KL: Blutdrucksenkung durch Fasten bei adiposen und nichtadiposen Hypertonikern. Perfusion 2001;14:108-112.
97. Dessi-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L, Espinosa E, Rappelli A: Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999;33:658-662.
98. Goldhamer AC: Initial cost of care results in medically supervised water-only fasting for treating high blood pressure and diabetes. J Altern Complement Med 2002;8:696-697.
99. Goldhamer A, Lisle D, Parpia B, Anderson SV, Campbell TC: Medically supervised water-only fasting in the treatment of hypertension. J Manipulative Physiol Ther 2001;24:335-339.
100. Schubmann R, Graban I, Holz G, Zwingmann C: Ergebnisqualitat stationarer Rehabilitation bei Patienten mit Adipositas. Deutsche Rentenversicherung 1997;9-10:1-22.
101. Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB; Intermountain Heart Collaborative Study: Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 2008;102:814-819.
102. Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan MI: Chronic alternate-day fasting results in reduced diastolic compliance and diminished systolic reserve in rats. J Card Fail 2010;16:843-853.
103. Watts NB, DiGirolamo M: Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes. Am J Med Sci 1990;299:250-256.
104. Li C, Ostermann T, Hardt M, Ludtke R, Broecker- Preuss M, Dobos G, Michalsen A: Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome. Forsch Komplementmed 2013;20:413-420.
105. Stange R, Pflugbeil C, Michalsen A, Uehleke B: Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance. Forsch Komplementmed 2013;20:421-426.
106. Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD: Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA 2008;105:8215-8220.
107. Lee C, Longo VD: Fasting vs dietary restriction in cellular protection and cancer treatment: From model organisms to patients. Oncogene 2011;30: 3305-3316.
108. Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R, Longo VD: Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemo therapy. Sci Transl Med 2012;4:124ra127.
109. Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G, Longo VD: Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res 2010;70:1564-1572.
110. Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD: Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol 2013;48:1120-1128.
111. Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD: Fasting and cancer treatment in humans: A case series report. Aging 2009;1:988-1007.
112. Michalsen A: Stressed patients, stressed physicians and the need for mind-body medicine. Forsch Komplementmed 2010;17:237-239.
113. Michalsen A, Frey UH, Merse S, Siffert W, Dobos GJ: Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism. Ann Nutr Metab 2009;54:184-188.
114. Michalsen A, Weidenhammer W, Melchart D, Langhorst J, Saha J, Dobos G: Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes - well-being and side effects with and without mineral supplements. Forsch Komplementarmed Klass Naturheilkd 2002;9:221-227.
115. Roky R, Houti I, Moussamih S, Qotbi S, Aadil N: Physiological and chronobiological changes during Ramadan intermittent fasting. Ann Nutr Metab 2004;48:296-303.
116. Hussin NM, Shahar S, Teng NI, Ngah WZ, Das SK: Efficacy of fasting and calorie restriction (FCR) on mood and depression among ageing men. J Nutr Health Aging 2013;17:674-680.
117. Wilhelmi de Toledo F, Friebe R, Hebisch D et al. : The Klinik Buchinger Programme for the treatment of obesity; in Ditschuneit H, Gries FA, Hautner H, et al. (eds): Obesity in Europe 1993. London, Libbey, 1994, pp 289-293.
118. Kanazawa M, Fukudo S: Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med 2006;13:214-220.
119. Schubmann R: Therapeutisches Fasten bei Adipositas und metabolischem Syndrom. Zeitschrift fur Komplementarmedizin 2009;1:14-17.
120. Peper E: Evaluation der Effekte und Erfolge von stationaren Heilfastenmassnahmen. Frankfurt/M., Lang, 1999.
121. Isner JM, Sours HE, Paris AL, Ferrans VJ, Roberts WC: Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval. Circulation 1979;60:1401-1412.
122. Spencer IO: Death during therapeutic starvation for obesity. Lancet 1968;1:1288-1290.
123. Frattali VP: Deaths associated with the liquid protein diet. Bull Natl Clgh Poison Control Cent 1979;23:4-11.
124. Hearing SD: Refeeding syndrome. BMJ 2004;328: 908-909.
125. Wilhelmi de Toledo F, Buchinger A, Gaisbauer M, et al.: Fasting therapy - a revised expert panel update of the 2002 consensus guidelines. Forsch Komplementmed 2013;20:444-453.